tiprankstipranks
Trending News
More News >
Bioxytran Inc (BIXT)
OTHER OTC:BIXT
US Market

Bioxytran (BIXT) Income Statement

Compare
20 Followers

Bioxytran Income Statement

Last quarter (Q1 2025), Bioxytran's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Bioxytran's net income was $-1.35M. See Bioxytran’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -8.29K$ -3.64K$ 0.00$ 0.00
Operating Expenses
$ 2.22M$ 3.82M$ 2.14M$ 4.21M$ 1.27M
Depreciation and Amortization
-$ 8.29K$ 3.64K$ 4.21M$ 1.27M
EBITDA
$ -2.22M$ -3.82M$ -2.13M$ -4.21M$ -1.27M
Operating Income
$ -2.22M$ -3.82M$ -2.13M$ -4.21M$ -1.27M
Other Income/Expenses
$ -156.94K$ -550.11K$ -523.19K$ -313.61K$ -1.27M
Pretax Income
$ -2.38M$ -4.37M$ -2.66M$ -4.53M$ -2.54M
Net Income
$ -2.37M$ -4.28M$ -2.46M$ -4.35M$ -3.75M
Per Share Metrics
Basic EPS
$ -0.02$ -0.03$ -0.02$ -0.04$ -0.04
Diluted EPS
$ -0.02$ -0.03$ -0.02$ -0.04$ -0.04
Weighted Average Shares Outstanding
138.60M 134.22M 115.14M 106.25M 93.97M
Weighted Average Shares Outstanding (Diluted)
138.60M 134.22M 115.14M 106.25M 93.97M
Currency in USD

Bioxytran Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis